• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book Apps
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Blogs » The Carlat Psychiatry Blog » Evaluating Memory Loss in Patients

The Carlat Psychiatry Blog
The Carlat Psychiatry Blog RSS FeedRSS

Evaluating Memory Loss in Patients

May 1, 2019
The old rule of thumb used to be that “you don’t need to worry about the person who’s worried about their memory; you need to worry about people who aren’t worried.” Although that might still be true for people already with dementia, it’s important that you pick up on memory problems at the mild cognitive impairment stage. The Carlat Psychiatry Report interviewed Andrew E. Budson, MD, Chief of Cognitive & Behavioral Neurology at Veterans Affairs Boston Healthcare System, who offers the following tips on evaluating a patient concerned about memory loss.

First, evaluate whether the memory loss is interfering with important aspects of life. For example:

  • Did they show up at the wrong place or the wrong time to meet a friend for lunch?

  • Did they forget to pick up the grandkids at soccer?

  • Did they forget about a dinner they had out? Although it’s normal to forget the name of a restaurant they went to last week, people should not have completely forgotten that they ate out at an Indian restaurant the week before.


If you determine that memory issues might be beyond what is consistent with normal aging, take the following steps to further evaluate:

  • Get information from caregivers and informants (this can be in the form of questionnaires to save time). For example, talk to people in the patient’s life to ask if the patient has been working harder to keep track of things. You may learn that things are just requiring much more effort than they used to.

  • Do pencil-and-paper testing. Dr. Budson’s preferred test is the MoCA (Montreal Cognitive Assessment). It’s more sensitive than the Mini-Mental State Examination, it’s freely available at www.mocatest.org., and it doesn’t take long to administer—about 10 minutes for most patients. The typical Alzheimer’s patient will do especially poorly on the part of the test where the person must read and immediately repeat a list of five words. Rapid forgetting is present if, after five minutes, a person is not able to freely recall the words.

  • If you suspect a problem, order a basic dementia workup to rule out reversible causes of cognitive impairment. Lab tests would typically include an MRI, CBC, electrolytes, thyroid panel, B12, and vitamin D. On the MRI, Alzheimer’s patients may show some atrophy of the hippocampus, anterior temporal lobes, and parietal lobes.


Our full interview with Dr. Budson includes advice for pharmacological treatment should a patient be diagnosed with dementia. It was published in the May 2017 issue of The Carlat Psychiatry Report. Subscribers can read it here.
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • HospPsychiatry_Spiral_Binding_Sm.png

    Hospital Psychiatry Fact Book, First Edition (2025) - Spiral Bound

    This comprehensive guide is designed to be a valuable resource for professionals working in...
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2637648401.jpg
    General Psychiatry

    Psychopharm Secrets: Coming Off Meds

    There’s a hidden placebo response to watch for when patients stop meds on their own.
    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.